Gastric transmucosal potential difference: effect of antisecretory and gastroprotective drugs
Related Experiment Video
Updated: Oct 30, 2026

Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease
Published on: February 9, 2016
V Nosál'ová1, A Babul'ová, V Bauer
1Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Slovak Republic.
Abstract:
1. Ion transport and electrical resistance of the gastric mucosa are responsible for the generation of the transmucosal potential difference (PD), which is considered an index of mucosal integrity. 2. The aim of the present work was to study the effect of some antisecretory and gastroprotective agents on PD in stomachs damaged by ethanol. 3. Control PD values measured in anesthetized rats were 35 to 40 mV (mucosa negative). Oral administration of 96% ethanol or intragastric instillation of 20% ethanol induced an abrupt fall in PD from the basal values of 40.4+/-1.0 mV and 39.6+/-0.1 mV to 14.6+/-2.5 mV and 11.7+/-1.3 mV, respectively. 4. Oral and/or topical pretreatment with the antisecretory agents ranitidine and timoprazole, as well as with the gastroprotective agents PGE2 and pentacaine, but not with an aluminum- and magnesium-containing antacid and with sucralfate, reduced the maximal drop of PD caused by ethanol. 5. After the administration of concentrated ethanol, hemorrhagic lesions were formed in the glandular stomach. 6. With the exception of ranitidine, all the drugs tested prevented the development of lesions after ethanol administration. 7. The results indicate that the gastric barrier can be protected by various drugs that act through different mechanisms.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
